HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Studies on prolactin-secreting cells in aging rats of different strains. II. Selected morphological and immunocytochemical features of pituitary tumors correlated with serum prolactin levels.

Abstract
Sixty pituitary tumors from 151 aging rats of the BN/BiRij strain, the WAG/Rij strain and their F1 hybrid were studied light microscopically. The lowest tumor incidence (18%) was found in the BN/BiRij strain, the highest incidence (71%) in the WAG/Rij strain. In the F1 hybrid the incidence (45%) was intermediate between those of the parental strains. With a hematoxylin-phloxin-saffron (HPS) staining two tumor types, i.e. hemorrhagic and solid could be distinguished. Immunocytochemical staining with anti-r-PRL antiserum revealed a positive reaction in the hemorrhagic and a negative reaction in the solid type, whereas staining with anti-sh-GH and anti-ACTH generally were negative. In animals with hemorrhagic as well as with solid tumors elevated serum PRL levels were found, although some differences were noticed. Serum levels in females of the WAG/Rij strain with hemorrhagic adenomas were significantly higher than the levels in females with solid adenomas. In the same strain, age-related differences in PRL levels were found. Significantly higher serum PRL levels were found at the age of 26-32 months than in older animals. The same tendencies were noticed in both other strains.
AuthorsL J van Putten, M J van Zwieten
JournalMechanisms of ageing and development (Mech Ageing Dev) Vol. 42 Issue 2 Pg. 115-27 (Feb 1988) ISSN: 0047-6374 [Print] Ireland
PMID3361964 (Publication Type: Journal Article)
Chemical References
  • Prolactin
Topics
  • Adenoma (blood)
  • Age Factors
  • Animals
  • Female
  • Immunohistochemistry
  • Male
  • Pituitary Neoplasms (blood, epidemiology, pathology)
  • Prolactin (blood, immunology)
  • Rats
  • Sex Factors
  • Species Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: